[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356473-105":59,"doc-detail-356473-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ubiquitin-c-terminal-hydrolase-l3-promotes-liver-cancer-cell-proliferation-by-modulating-the-amp-activated-protein-kinase-signaling-pathway","Ubiquitin C-terminal hydrolase L3 promotes liver cancer cell proliferation by modulating the AMP-activated protein kinase signaling pathway","","Deubiquitinase Ubiquitin C-terminal Hydrolase L3 (UCHL3) is highly expressed across cancers and typically considered an oncogene, but its liver cancer role is unclear. This study evaluates UCHL3 in liver cancer growth and clinical relevance as a prognostic marker using TCGA datasets and molecular assays. Functional tests show UCHL3 supports proliferation, impacts cell-cycle regulators, alters autophagy, and links suppression to AMPK pathway activation. Targeting UCHL3 may therefore inhibit liver cancer progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ubiquitin-c-terminal-hydrolase-l3-promotes-liver-cancer-cell-proliferation-by-modulating-the-amp-activated-protein-kinase-signaling-pathway/356473/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ubiquitin-c-terminal-hydrolase-l3-promotes-liver-cancer-cell-proliferation-by-modulating-the-amp-activated-protein-kinase-signaling-pathway/356473.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this study on UCHL3 in liver cancer?","Question",{"text":112,"@type":113},"The study investigates how UCHL3 affects liver cancer cell growth and assesses its potential clinical significance as a prognostic marker.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were UCHL3 expression and clinical correlations evaluated?",{"text":117,"@type":113},"UCHL3 expression in cancer and correlations with clinical parameters were assessed using TCGA databases, along with real time-PCR, Western blotting, and immunostaining.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links UCHL3 to liver cancer cell proliferation?",{"text":121,"@type":113},"UCHL3 promotes proliferation by maintaining cell-cycle regulator expression; its knockdown affects autophagy and is associated with activation of the AMPK signaling pathway, which helps control autophagy activation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356473,1790260799,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Journal of Cancer Research and Clinical Oncology (2026) 152:65  \n[https://doi.org/10.1007/s00432-026-06452-6](https://doi.org/10.1007/s00432-026-06452-6)  \nRESEARCH  \nUbiquitin C-terminal hydrolase L3 promotes liver cancer cell proliferation by modulating the AMP-activated protein kinase signaling pathway  \nYan Liu1 · Jingbo Lu2 · Hao Wang2 · Shimin Sun2 · Bin Guo2 · Xinyu Wang2 · Baoshuai Wang2 · Yishen Li2 · Tao Wu2  \nReceived: 7 May 2025 / Accepted: 22 February 2026 © The Author(s) 2026  \nAbstract  \nPurpose The deubiquitinase Ubiquitin C-Terminal Hydrolase L3 (UCHL3) is highly expressed in multiple cancer types and generally considered as an oncogene. However, its functions in liver cancer are unclear. This study investigated the role of UCHL3 in liver cancer cell growth and evaluated its potential clinical significance as a prognostic marker.  \nMethods The expression of UCHL3 in cancer and its correlations with clinical parameters were assessed by using TCGA databases. Gene expression was analyzed by real time-PCR, Western Blotting, and immunostaining. Colony formation assays were performed and growth curve were measured to evaluate the function of UCHL3 in liver cancer cell proliferation. Gene Set Enrichment Analysis (GSEA) was used to explore enriched pathways.  \nResults We found that UCHL3 was essential in promoting liver cancer cell proliferation. It was highly expressed in liver cancer tissues and was a negative prognostic marker for liver cancer. Knocking down UCHL3 reduced the expression of cell cycle regulators, such as Cyclin A2, Cyclin B1 and MAD2, inhibiting cell cycle progression. The inhibition was partially due to the alteration of autophagy upon UCHL3 deprivation, as disruption of autophagy restored the protein level of Cyclin B1 and reversed cell cycle arrest. Suppressing UCHL3 was associated with the activation of AMP-activated protein kinase (AMPK) signaling pathway, which was important in controlling autophagy activation.  \nConclusion UCHL3 may negatively modulate the AMPK pathway and autophagy in liver cancer to maintain the expression of cell cycle regulators and facilitate cell proliferation. Targeting overexpressed UCHL3 may be feasible to inhibit liver cancer progression.  \nKeywords UCHL3 · Cell cycle · Autophagy · AMPK · Liver cancer  \nYan Liu, Jingbo Lu and Hao Wang have contributed equally to this work and share first authorship.  \n􀀍 Yishen Li [marine_lee1999@outlook.com](marine_lee1999@outlook.com)  \n􀀍 Tao Wu [wut@cpu.edu.cn](wut@cpu.edu.cn)  \n1 Department of Pathology, Baogang Hospital of InnerMongolia, The Third Affiliated Hospital of InnerMongolia Medical University, 20 Shaoxian Road, Kun District, Baotou 014010, People’s Republic of China  \n2 State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, People’s Republic of China  \nIntroduction  \nUbiquitination is a post-translational modification which regulates protein localization and degradation, signal transduction, gene transcription, DNA damage repair, as well as cell cycle progression (Komander and Rape 2012) . By ubiquitination, target proteins are covalently attached with a or multiple ubiquitin (Ub) proteins through a cascade of enzymes including E1 (Ub-activating enzyme), E2 (Ub-conjugating enzyme), and E3 (Ub ligase) . In contrast, protein ubiquitination in cell can be reversed by deubiquitinases (DUBs), which remove ubiquitin from its substrates. Aberrant DUBs are engaged in various diseases, including cancer, neurodegeneration and inflammation, making them attractive drug targets for disease treatment (Harrigan et al. 2018) .  \n1 3  \nUbiquitin C-Terminal Hydrolase L3 (UCHL3) is a deubiquitinase that were engaged in a variety of cellular processes. It regulated the ubiquitination and localization of Aurora B, controlling the progress of mitosis (Jerabkova et al. 2020) . Additi","cbCaiuzWBxLDWNsD","https://ap.wps.com/l/cbCaiuzWBxLDWNsD","pdf",3872407,12,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main purpose of this study on UCHL3 in liver cancer?\",\"answer\":\"The study investigates how UCHL3 affects liver cancer cell growth and assesses its potential clinical significance as a prognostic marker.\"},{\"question\":\"How were UCHL3 expression and clinical correlations evaluated?\",\"answer\":\"UCHL3 expression in cancer and correlations with clinical parameters were assessed using TCGA databases, along with real time-PCR, Western blotting, and immunostaining.\"},{\"question\":\"What mechanism links UCHL3 to liver cancer cell proliferation?\",\"answer\":\"UCHL3 promotes proliferation by maintaining cell-cycle regulator expression; its knockdown affects autophagy and is associated with activation of the AMPK signaling pathway, which helps control autophagy activation.\"}]","Ubiquitin C-terminal hydrolase L3 promotes liver cancer cell proliferation by modulating the AMP-activated protein kinase signaling pathway | PDF",1790125475,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d171a802a4a00192827539e9e17233c.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89cdf4ac2560bc5d3b8674fb03a8978b.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d7e862f364b51227e0cb15473a77967.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd4d8c6cecbb7569f5944ce246f6d959.webp",980,1301]